_id
691843d13c536f8df231771b
Ticker
XENO
Name
Xeno Transplants Corporation
Exchange
OTCCE
Address
143 Gardner Road, Brookline, MA, United States, 02445
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
-
Description
Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species into humans, such as swine. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-08T13:04:30.883Z
Ipo Date
-
Market Cap
64582
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2008-03-31
Revenue
0
Cost Of Revenue
0
Gross Profit
0
Operating Expenses
109774
Operating Income
-109774
Interest Expense
-
Pretax Income
-109774
Net Income
-109774
Eps
-
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
0
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
0
Cash
261
Short Term Investments
-
Receivables
100000
Inventories
-
Total Current Assets
100261
Property Plant Equipment
1391
Total Assets
1078883
Payables
286343
Short Term Debt
502231
Long Term Debt
-
Total Liabilities
1045605
Equity
33278
Bs_currency_symbol
USD
Depreciation
144
Change In Working Capital
-
Cash From Operations
-53998
Capital Expenditures
0
Cash From Investing
-118062
Cash From Financing
171958
Net Change In Cash
-102
Cf_currency_symbol
USD
PE
-
PB
-
ROE
-329.8695835086243
ROA
-10.174782622397425
FCF
-53998
Fcf Percent
-
Piotroski FScore
1
Health Score
26
Deep Value Investing Score
1.5
Defensive Investing Score
4
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
1
Quality Investing Score
1.5
Value Investing Score
1.5
Quarters > 0 > quarter
2008-03-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
0
Quarters > 0 > income Statement > gross Profit
0
Quarters > 0 > income Statement > operating Expenses
109774
Quarters > 0 > income Statement > operating Income
-109774
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-109774
Quarters > 0 > income Statement > net Income
-109774
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
261
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
100000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
100261
Quarters > 0 > balance Sheet > property Plant Equipment
1391
Quarters > 0 > balance Sheet > total Assets
1078883
Quarters > 0 > balance Sheet > payables
286343
Quarters > 0 > balance Sheet > short Term Debt
502231
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1045605
Quarters > 0 > balance Sheet > equity
33278
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-109774
Quarters > 0 > cash Flow > depreciation
144
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-53998
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-118062
Quarters > 0 > cash Flow > cash From Financing
171958
Quarters > 0 > cash Flow > net Change In Cash
-102
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-329.8695835086243
Quarters > 0 > ratios > ROA
-10.174782622397425
Quarters > 0 > ratios > FCF
-53998
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
26
Quarters > 1 > quarter
2007-12-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
0
Quarters > 1 > income Statement > gross Profit
0
Quarters > 1 > income Statement > operating Expenses
170149
Quarters > 1 > income Statement > operating Income
-170149
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-170149
Quarters > 1 > income Statement > net Income
-170149
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
363
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
100000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
100363
Quarters > 1 > balance Sheet > property Plant Equipment
1535
Quarters > 1 > balance Sheet > total Assets
961067
Quarters > 1 > balance Sheet > payables
219492
Quarters > 1 > balance Sheet > short Term Debt
330273
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
818015
Quarters > 1 > balance Sheet > equity
143052
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-170149
Quarters > 1 > cash Flow > depreciation
144
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-24324
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-182629
Quarters > 1 > cash Flow > cash From Financing
203716
Quarters > 1 > cash Flow > net Change In Cash
-3237
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-118.9420630260325
Quarters > 1 > ratios > ROA
-17.704176711925392
Quarters > 1 > ratios > FCF
-24324
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2007-09-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
0
Quarters > 2 > income Statement > gross Profit
0
Quarters > 2 > income Statement > operating Expenses
140838
Quarters > 2 > income Statement > operating Income
-140838
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-140838
Quarters > 2 > income Statement > net Income
-140838
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3600
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
25000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
29060
Quarters > 2 > balance Sheet > property Plant Equipment
1679
Quarters > 2 > balance Sheet > total Assets
782279
Quarters > 2 > balance Sheet > payables
156080
Quarters > 2 > balance Sheet > short Term Debt
126557
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
469078
Quarters > 2 > balance Sheet > equity
313201
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-140838
Quarters > 2 > cash Flow > depreciation
48
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-26811
Quarters > 2 > cash Flow > capital Expenditures
1727
Quarters > 2 > cash Flow > cash From Investing
-106685
Quarters > 2 > cash Flow > cash From Financing
105000
Quarters > 2 > cash Flow > net Change In Cash
-28496
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-44.967289376470696
Quarters > 2 > ratios > ROA
-18.003551162692595
Quarters > 2 > ratios > FCF
-28538
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2007-06-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
0
Quarters > 3 > income Statement > gross Profit
0
Quarters > 3 > income Statement > operating Expenses
0
Quarters > 3 > income Statement > operating Income
-86772
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-86772
Quarters > 3 > income Statement > net Income
-86772
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
32096
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
37827
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
641409
Quarters > 3 > balance Sheet > payables
255369
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
255369
Quarters > 3 > balance Sheet > equity
386040
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-86772
Quarters > 3 > cash Flow > depreciation
-420
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-102609
Quarters > 3 > cash Flow > capital Expenditures
1727
Quarters > 3 > cash Flow > cash From Investing
145205
Quarters > 3 > cash Flow > cash From Financing
-43549
Quarters > 3 > cash Flow > net Change In Cash
-953
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-22.477463475287536
Quarters > 3 > ratios > ROA
-13.528341510642974
Quarters > 3 > ratios > FCF
-104336
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2007-06-30
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
0
Annuals > 0 > income Statement > gross Profit
0
Annuals > 0 > income Statement > operating Expenses
255674
Annuals > 0 > income Statement > operating Income
-255674
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-256370
Annuals > 0 > income Statement > net Income
-256370
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-696
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
32096
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1971
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
641409
Annuals > 0 > balance Sheet > payables
15000
Annuals > 0 > balance Sheet > short Term Debt
21557
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
255369
Annuals > 0 > balance Sheet > equity
386040
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-256370
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-6556
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-70232
Annuals > 0 > cash Flow > cash From Financing
78938
Annuals > 0 > cash Flow > net Change In Cash
2150
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-66.41021655786965
Annuals > 0 > ratios > ROA
-39.96981645096967
Annuals > 0 > ratios > FCF
-6556
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
32
Annuals > 1 > quarter
2006-06-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
0
Annuals > 1 > income Statement > operating Expenses
0
Annuals > 1 > income Statement > operating Income
-46657
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-46657
Annuals > 1 > income Statement > net Income
-46657
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
29
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
29
Annuals > 1 > balance Sheet > property Plant Equipment
768
Annuals > 1 > balance Sheet > total Assets
797
Annuals > 1 > balance Sheet > payables
13321
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
13321
Annuals > 1 > balance Sheet > equity
-12524
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-46657
Annuals > 1 > cash Flow > depreciation
353
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-26433
Annuals > 1 > cash Flow > capital Expenditures
1121
Annuals > 1 > cash Flow > cash From Investing
-1121
Annuals > 1 > cash Flow > cash From Financing
331451
Annuals > 1 > cash Flow > net Change In Cash
-27554
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
372.54072181411686
Annuals > 1 > ratios > ROA
-5854.077791718946
Annuals > 1 > ratios > FCF
-27554
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
40
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
-329.8695835086243
Profitability > metrics > ROA
-109.48823570481045
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
31.42030771079993
Risk > final Score
26
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.12714215786977506
Liquidity > metrics > Quick Ratio
0.12714215786977506
Liquidity > final Score
16
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
26
Prev Risks > 1
50
Prev Risks > 2
68
Prev Liquidities > 0
19
Prev Liquidities > 1
15
Prev Liquidities > 2
17
Updated At
2026-01-20T22:50:35.047Z
Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species into humans, such as swine. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARepare Therapeutics Shareholders Approve Acquisition by XenoTherapeutics TipRanks
Read more ā99.76% of Repare voters back takeover by nonprofit XenoTherapeutics Stock Titan
Read more āShowing 2 of 10
(Last Updated 2008-03-31)
Health Score
Return on Equity (ROE)
-
Very Low
Low ⤠5%
High ā„ 25%
Return on Assets (ROA)
-
Very Low
Low ⤠2%
High ā„ 10%
Debt to Equity
-
Very Low
Low ā„ 1
High ⤠0.3
* Institutions hold a combined 0.00% of the total shares of Xeno Transplants Corporation
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2008-03-31)
(Last Updated 2008-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2008-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2008-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.